Table 3.

Associations between clinical outcomes (pre-intervention) and improvements in VO₂ max and peak power output following the exercise intervention.

	Improvement in VO2 max (ml/min/kg)						Improvement in peak power output (watt)
Clinical outcomes (pre-intervention)	β	S.E	P	β adjustedb	S.E.	P	β	S.E	P	β adjustedc	S.E.	P
ACQ	−0.84	1.18	0.49	−0.85	1.2	0.50	3.7	7.8	0.64	4.3	8.2	0.61
FEV1%pred.	0.01	0.06	0.82	0.02	0.06	0.81	0.46	0.36	0.22	0.41	0.37	0.28
AHR a (n = 28)	0.84	1.5	0.58	0.88	5.4	0.59	4.2	9.8	0.67	5.5	10.1	0.60
FeNO (ppb)	−0.01	0.04	0.80	−0.01	0.04	0.82	0.24	0.26	0.37	0.30	0.29	0.30

FEV₁%pred. = Forced expiratory volume in one second in percent of predicted.

AHR = Airway hyperresponsiveness.

FeNO (ppb) = Fractional exhaled nitric oxide (parts per billion).

^a Log response-dose slopes.

^b Adjusted for baseline VO₂ max (ml/min/kg) and sex.

^c Adjusted for baseline peak power output and sex.